Atai Life Sciences NV Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SCHEDULE 13G/A: Galaxy Group Entities Reduce Stake in ATAI Life Sciences to 4.2%
Galaxy Group Funding ECI U LLC, Galaxy Group Investments LLC, and Michael E. Novogratz have collectively reduced their beneficial ownership in ATAI Life Sciences N.V. to 4.2% of common shares.